Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Operating Expenses | 16,717 | 15,598 | 14,775 | 8,600 | 7,420 |
| Operating Income | -16,717 | -15,598 | -14,775 | -8,600 | -7,420 |
| Other Income | 117 | 13 | 11 | 6 | 3 |
| Pre-tax Income | -16,600 | -15,585 | -14,764 | -8,594 | -7,417 |
| Net Income Continuous | -16,600 | -15,585 | -14,764 | -8,594 | -7,417 |
| Net Income | $-16,600 | $-15,585 | $-14,764 | $-8,594 | $-7,417 |
| EPS Basic Total Ops | -0.56 | 6.01 | -0.90 | -4.84 | -4.22 |
| EPS Basic Continuous Ops | -0.56 | 4.72 | -0.85 | -3.87 | -3.61 |
| EPS Diluted Total Ops | -0.56 | 6.01 | -0.90 | -4.84 | -4.22 |
| EPS Diluted Continuous Ops | -0.56 | 4.72 | -0.85 | -3.87 | -3.61 |
| EBITDA(a) | $-16,475 | $-15,331 | $-14,558 | $-8,394 | $-7,237 |